How useful are medication patient information leaflets to older adults? A content, readability and layout analysis
- 1k Downloads
Background Patient information leaflets (PILs) are the most important information source for older patients to effectively manage their drug therapy. Objective The objective of this study is to evaluate the appropriateness of current available PILs for use by older adults. Methods The content of the PILs were assessed by checking the availability of information relevant to older patients including pharmacokinetics, safety and dose instructions. The layout of the PILs was evaluated using criteria derived from the relevant regulatory guidelines on the design of PILs. The Gunning Fog Index was used to determine the readability of the PILs to older adults. Results Total of 48 PILs were analysed involving 25 drug substances for the treatment of cardiovascular disease and type 2 diabetes. One out of the 48 PILs contained information on pharmacokinetic changes in older patients and only 15 % of the PILs specified the age of the older person. Thirty-one percent of the PILs provided nonspecific warnings to the older population, while only 15 % included specific side effects that could occur in the older generation. Text font sizes of the PILs were generally too small for older adults to read, with only 9 % of the PILs used type size 12 or over. The readability of 63 % of the PILs had a score above 12, which is considered difficult for older people to understand. Conclusion Currently available medication PILs are inappropriate for use by older adults to manage their medications effectively, which could adversely affect patient safety and adherence to drug therapy.
KeywordsElderly Geriatric information Layout Older Patient information leaflet PIL Readability United Kingdom
Conflicts of interest
- 1.United Nations, World Population Ageing: 1950–2050. http://www.un.org/esa/population/publications/worldageing19502050/pdf/preface_web.pdf. 2001. Accessed 06 May 2014.
- 4.European Commission. Directive 2004/27/EC of 31 March 2004 amending Directive 2001/83/EC on the community code relating to medicinal products for human use. 2004. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0034:0057:EN:PDF. Accessed 06 May 2014.
- 5.European Commision. A guideline on summary of product characteristics (SmPC). 2009. http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf. Accessed 06 May 2014.
- 8.International Conference on Harmonization (ICH). E7–studies in support of special populations: geriatrics. 1993. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf. Accessed 06 May 2014.
- 9.European Medicines Agency (EMA). ICH topic E7-Studies in support of special populations: geriatrics; questions and answers. 2010. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500005218.pdf. Accessed 06 May 2014.
- 13.European Commission. Guideline of the readability of the labelling and package leaflet of medicinal products for human use. 2009. http://ec.europa.eu/health/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf. Accessed 06 May 2014.
- 14.Medicines and Healthcare products Regulatory Agency (MHRA). Always read the leaflet: getting the best information with every medicine. 2004. http://www.mhra.gov.uk/home/groups/pl-/documents/publication/con2018041.pdf. Accessed 06 May 2014.
- 15.NHS information Center for Health and Social care. Prescription cost analysis—England. 2012. http://www.nhsbsa.nhs.uk/PrescriptionServices/3494.aspx. Accessed 06 May 2014.
- 16.British Medical Association and the Royal Pharmaceutical Society. The British National Formulary (BNF). 65th ed. London: BMJ Group and Pharmaceutical Press; 2013.Google Scholar
- 17.Datapharm Communications Limited. The electronic medicines compendium (eMC). http://www.medicines.org.uk/emc/. Accessed 06 May 2014.
- 26.Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Libr Inf Res. 2001;25:3–12.Google Scholar
- 31.News Team. Medicines safety experts call for rewrite of packaging regulations. Pharm J. 2013;291:424.Google Scholar
- 32.European Medicines Agency (EMA). Ensuring safe and effective medicines for an ageing population: workshop proceedings. 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2012/02/WC500122493.pdf. Accessed 06 May 2014.